Title : Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations.

Pub. Date : 2021 May

PMID : 33684714






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In this regard, the present work aims at developing a new set of small molecules featuring the privileged isatin scaffold conjugated with a thiazolo[3,2-a]benzimidazole (TBI) motif through a cleavable hydrazide linker (7a-e and 10a-i) as potential anticancer CDK2 inhibitors. hydrazide cyclin dependent kinase 2 Homo sapiens